Clinical review. Recombinant human GM-CSF in the treatment of poorly healing wounds.
Although most wounds heal rapidly, impaired or delayed tissue repair represents a major clinical challenge. Current therapy is directed at providing a wound with the most favorable environment in which to heal, rather than aiming to increase the rate of healing pharmacologically. Recent studies have...
| Publicado en: | Advances in Skin & Wound Care Vol. 13; no. 3 part 1; pp. 107 - 113 |
|---|---|
| Autores principales: | , |
| Formato: | review tables/charts Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
2000 May-Jun
|
| Acceso en línea: | Ver este registro en EBSCOhost |